1. Home
  2. XBIT vs UFI Comparison

XBIT vs UFI Comparison

Compare XBIT & UFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

N/A

Current Price

$1.88

Market Cap

69.8M

Sector

Health Care

ML Signal

N/A

Logo Unifi Inc. New

UFI

Unifi Inc. New

N/A

Current Price

$5.82

Market Cap

76.4M

ML Signal

N/A

Company Overview

Basic Information
Metric
XBIT
UFI
Founded
2005
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Textiles
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
69.8M
76.4M
IPO Year
2015
1994

Fundamental Metrics

Financial Performance
Metric
XBIT
UFI
Price
$1.88
$5.82
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
92.8K
★ 130.7K
Earning Date
11-20-2026
10-29-2026
Dividend Yield
N/A
★ 28.43%
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $531,303,000.00
Revenue This Year
N/A
$3.29
Revenue Next Year
$30.47
$10.79
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.80
$2.96
52 Week High
$3.44
$8.47

Technical Indicators

Market Signals
Indicator
XBIT
UFI
Relative Strength Index (RSI) 39.12 50.32
Support Level $1.80 $5.95
Resistance Level $2.42 $6.75
Average True Range (ATR) 0.12 0.31
MACD -0.00 0.07
Stochastic Oscillator 27.27 46.92

Price Performance

Historical Comparison
XBIT
UFI

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

About UFI Unifi Inc. New

Unifi Inc is a multi-national company. It manufactures and sells synthetic and recycled products made from polyester and nylon predominantly to other yarn manufacturers and knitters and weavers that produce fabric for apparel, hosiery, home furnishings, automotive, industrial, and other end-use markets. Polyester yarns include partially oriented yarn (POY), textured, solution and package dyed, twisted, beamed, and draw wound yarns, and each is available in virgin or recycled varieties. UNIFI offers specialized yarns, premium value-added (PVA) yarns, and commodity yarns. The company's reportable segments are; the Americas, Brazil, and Asia. Its maximum revenue is derived from the Americas.

Share on Social Networks: